The following article appeared on July 11, 2025 on Bloomberg Law.   While the Federal Trade Commission’s lawsuit against pharmacy benefit manager giants is paused by a temporary stay, lawsuits from state attorneys general and private plaintiffs offer prime opportunities for attorneys to hold pharmacy benefit managers accountable. State lawsuits are rewriting the rules, demanding agile litigation […]

The following article appeared on February 21, 2025 on Law360 UK. The Rise of GLP-1 Agonists The rapid ascent of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) — such as Novo Nordisk’s Ozempic and Wegovy, and Eli Lilly & Co.’s Mounjaro and Zepbound — has revolutionized diabetes management and weight loss. However, this surge has triggered […]